LPL Financial’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $359K | Sell |
4,786
-20,852
| -81% | -$1.34M | ﹤0.01% | 5306 |
|
|
2026
Q1 | $1.44M | Sell |
25,638
-16,702
| -39% | -$1.09M | ﹤0.01% | 3818 |
|
|
2025
Q4 | $3.39M | Buy |
42,340
+2,756
| +7% | +$185K | ﹤0.01% | 2889 |
|
|
2025
Q3 | $1.93M | Sell |
39,584
-10,020
| -20% | -$620K | ﹤0.01% | 3349 |
|
|
2025
Q2 | $3.7M | Buy |
49,604
+4,506
| +10% | +$298K | ﹤0.01% | 2557 |
|
|
2025
Q1 | $2.67M | Buy |
45,098
+992
| +2% | +$67.5K | ﹤0.01% | 2698 |
|
|
2024
Q4 | $3.26M | Buy |
44,106
+14,806
| +51% | +$1.19M | ﹤0.01% | 2432 |
|
|
2024
Q3 | $2.36M | Buy |
29,300
+4,603
| +19% | +$372K | ﹤0.01% | 2571 |
|
|
2024
Q2 | $2.04M | Buy |
24,697
+4,272
| +21% | +$376K | ﹤0.01% | 2579 |
|
|
2024
Q1 | $1.74M | Buy |
20,425
+1,014
| +5% | +$79.6K | ﹤0.01% | 2648 |
|
|
2023
Q4 | $1.66M | Buy |
19,411
+878
| +5% | +$75.9K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $1.64M | Buy |
18,533
+1,991
| +12% | +$178K | ﹤0.01% | 2472 |
|
|
2023
Q2 | $1.41M | Buy |
16,542
+1,149
| +7% | +$97.1K | ﹤0.01% | 2566 |
|
|
2023
Q1 | $1.27M | Buy |
15,393
+2,405
| +19% | +$195K | ﹤0.01% | 2548 |
|
|
2022
Q4 | $982K | Buy |
12,988
+1,395
| +12% | +$112K | ﹤0.01% | 2661 |
|
|
2022
Q3 | $858K | Sell |
11,593
-245
| -2% | -$17.6K | ﹤0.01% | 2663 |
|
|
2022
Q2 | $776K | Sell |
11,838
-2,368
| -17% | -$140K | ﹤0.01% | 2809 |
|
|
2022
Q1 | $874K | Buy |
14,206
+2,685
| +23% | +$146K | ﹤0.01% | 2717 |
|
|
2021
Q4 | $614K | Sell |
11,521
-195
| -2% | -$11.9K | ﹤0.01% | 3102 |
|
|
2021
Q3 | $818K | Sell |
11,716
-1,573
| -12% | -$99.3K | ﹤0.01% | 2791 |
|
|
2021
Q2 | $886K | Buy |
13,289
+2,870
| +28% | +$203K | ﹤0.01% | 2668 |
|
|
2021
Q1 | $1.16M | Buy |
10,419
+4,566
| +78% | +$565K | ﹤0.01% | 2272 |
|
|
2020
Q4 | $695K | Buy |
5,853
+307
| +6% | +$33.1K | ﹤0.01% | 2474 |
|
|
2020
Q3 | $484K | Buy |
5,546
+2,829
| +104% | +$247K | ﹤0.01% | 2494 |
|
|
2020
Q2 | $243K | Buy |
+2,717
| New | +$274K | ﹤0.01% | 2988 |
|
|
2019
Q3 | – | Sell |
-5,793
| Closed | -$697K | – | 3326 |
|
|
2019
Q2 | $697K | Buy |
+5,793
| New | +$570K | ﹤0.01% | 1995 |
|
|
2019
Q1 | – | Sell |
-11,644
| Closed | -$1.17M | – | 3213 |
|
|
2018
Q4 | $1.17M | Buy |
11,644
+448
| +4% | +$47.1K | ﹤0.01% | 1418 |
|
|
2018
Q3 | $1.28M | Buy |
+11,196
| New | +$1.16M | ﹤0.01% | 1486 |
|
|
2015
Q1 | – | Sell |
-6,074
| Closed | -$227K | – | 2822 |
|
|
2014
Q4 | $227K | Sell |
6,074
-110
| -2% | -$4.03K | ﹤0.01% | 2397 |
|
|
2014
Q3 | $213K | Sell |
6,184
-670
| -10% | -$23.9K | ﹤0.01% | 2408 |
|
|
2014
Q2 | $242K | Buy |
+6,854
| New | +$229K | ﹤0.01% | 2356 |
|
Other funds holding HAE
AI
LPL Financial's HAE Position: Q2 2026 in Review
LPL Financial reduced its Haemonetics (HAE) stake by 81% in Q2 2026, selling an estimated $1.34M and leaving 4,786 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #5306.
LPL Financial first reported a position in HAE in Q2 2014 and has held it in 31 quarters since. The position peaked at $3.7M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- LPL Financial held 4,786 shares of Haemonetics worth $359K as of Q2 2026.
- LPL Financial sold 20,852 Haemonetics shares in Q2 2026, an estimated $1.34M.
- Haemonetics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5306 holding.
- LPL Financial first reported a position in Haemonetics in Q2 2014 and has held it in 31 quarters since.
- LPL Financial's Haemonetics position peaked at $3.7M in Q2 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.